Allogene Therapeutics Inc (ALLO)

Cash & Short-Term Investments

$332.60M

Quarterly · Period ending: · USD

ALLO logo

ALLO Cash & Short-Term Investments

Latest reported$332.60M
ALLO Quarterly Cash & Short-Term Investments ($293.93M → $332.60M)
High-resolution chart · PNG

ALLO cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Allogene Therapeutics Inc Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
332,604,000
266,886,000
250,210,000
252,194,000
273,120,000
280,043,000
292,476,000
291,564,000
444,628,000
384,860,000
448,697,000
465,505,000
491,962,000
471,224,000
517,320,000
552,229,000
490,492,000
449,050,000
457,302,000
483,485,000
587,707,000
699,581,000
827,910,000
841,022,000
899,650,000
492,923,000
530,533,000
501,244,000
650,193,000
466,140,000
721,350,000
244,221,000
293,927,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.